Skip to main content
. 2018 Apr 29;2018:2086163. doi: 10.1155/2018/2086163

Figure 3.

Figure 3

The levels of the plasma gastrointestinal hormones in FC patients and control group. FC patients showed a decreased plasma level of 5-HT, motilin, and VIP and an increased plasma level of somatostatin (all; P < 0.05 versus control group). The 4-week TN treatment increased plasma levels of 5-HT and motilin and decreased the plasma level of somatostatin in FC patients (P < 0.05 versus before treatment).